NO20025399L - Phosphate transport inhibitors - Google Patents

Phosphate transport inhibitors

Info

Publication number
NO20025399L
NO20025399L NO20025399A NO20025399A NO20025399L NO 20025399 L NO20025399 L NO 20025399L NO 20025399 A NO20025399 A NO 20025399A NO 20025399 A NO20025399 A NO 20025399A NO 20025399 L NO20025399 L NO 20025399L
Authority
NO
Norway
Prior art keywords
transport inhibitors
phosphate transport
phosphate
inhibitors
transport
Prior art date
Application number
NO20025399A
Other languages
Norwegian (no)
Other versions
NO20025399D0 (en
Inventor
Joseph Weinstock
Gerald Girard
Dimitri Gaitanopoulos
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of NO20025399D0 publication Critical patent/NO20025399D0/en
Publication of NO20025399L publication Critical patent/NO20025399L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Rheumatology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO20025399A 2000-05-12 2002-11-11 Phosphate transport inhibitors NO20025399L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US20399500P 2000-05-12 2000-05-12
PCT/US2001/015324 WO2001087294A1 (en) 2000-05-12 2001-05-11 Phosphate transport inhibitors

Publications (2)

Publication Number Publication Date
NO20025399D0 NO20025399D0 (en) 2002-11-11
NO20025399L true NO20025399L (en) 2002-11-11

Family

ID=22756167

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20025399A NO20025399L (en) 2000-05-12 2002-11-11 Phosphate transport inhibitors

Country Status (14)

Country Link
JP (1) JP2003533477A (en)
KR (1) KR20020093983A (en)
CN (1) CN1429108A (en)
AU (1) AU2001261471A1 (en)
BR (1) BR0110034A (en)
CA (1) CA2408667A1 (en)
CZ (1) CZ20023701A3 (en)
HU (1) HUP0302234A2 (en)
IL (1) IL152587A0 (en)
MX (1) MXPA02011160A (en)
NO (1) NO20025399L (en)
PL (1) PL359931A1 (en)
WO (1) WO2001087294A1 (en)
ZA (1) ZA200209106B (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2378179A (en) * 2001-08-03 2003-02-05 Pantherix Ltd Aromatic sulfonamides and their use in treating bacterial diseases
US7119120B2 (en) 2001-12-26 2006-10-10 Genzyme Corporation Phosphate transport inhibitors
KR20170091783A (en) 2008-12-31 2017-08-09 알데릭스, 인코포레이티드 Compounds and methods for inhibiting nhe-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
WO2018129556A1 (en) 2017-01-09 2018-07-12 Ardelyx, Inc. Compounds and methods for inhibiting nhe-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
US10376481B2 (en) 2012-08-21 2019-08-13 Ardelyx, Inc. Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
AU2013304812B2 (en) 2012-08-21 2016-06-09 Ardelyx, Inc. Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
CN103183623A (en) * 2013-03-12 2013-07-03 中国医学科学院医药生物技术研究所 A group of benzene sulfonamido benzamide derivatives, and preparation and application thereof
SMT201900386T1 (en) * 2013-04-12 2019-09-09 Ardelyx Inc Nhe3-binding compounds and methods for inhibiting phosphate transport
US9765050B2 (en) 2014-12-30 2017-09-19 Novira Therapeutics, Inc. Pyridyl reverse sulfonamides for HBV treatment
CN105395532B (en) * 2015-11-25 2017-11-14 中国医学科学院医药生物技术研究所 Application of the 2 benzene sulfonamido benzamide compounds in liver injury protection and liver fibrosis preventing and treating
US10793520B2 (en) 2016-08-30 2020-10-06 Nippon Soda Co., Ltd. Sulfonylaminobenzamide compound and pest control agent
JP2020505333A (en) 2017-01-09 2020-02-20 アルデリックス， インコーポレイテッド Inhibitors of NHE-mediated antiport
AU2018205400C1 (en) 2017-01-09 2026-01-15 Ardelyx, Inc. Compounds useful for treating gastrointestinal tract disorders
WO2019232384A1 (en) * 2018-06-01 2019-12-05 Promega Corporation Inhibitors of oplophorus luciferase-derived bioluminescent complexes

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0011571A (en) * 1999-06-24 2002-03-05 Smithkline Beecham Corp Macrophage cleaning receptor antagonists
CO5190714A1 (en) * 1999-07-20 2002-08-29 Smithkline Beecham Corp PHOSPHATE TRANSPORTATION INHIBITORS

Also Published As

Publication number Publication date
NO20025399D0 (en) 2002-11-11
KR20020093983A (en) 2002-12-16
IL152587A0 (en) 2003-05-29
WO2001087294A1 (en) 2001-11-22
ZA200209106B (en) 2003-10-23
HUP0302234A2 (en) 2003-11-28
MXPA02011160A (en) 2003-03-10
PL359931A1 (en) 2004-09-06
CA2408667A1 (en) 2001-11-22
JP2003533477A (en) 2003-11-11
CZ20023701A3 (en) 2003-11-12
BR0110034A (en) 2003-05-27
AU2001261471A1 (en) 2001-11-26
CN1429108A (en) 2003-07-09

Similar Documents

Publication Publication Date Title
DE60002193D1 (en) METALOPROTEASE INHIBITORS
ATE433451T1 (en) XANTHINE PHOSPHODIESTERAS V INHIBITORS
DE60017180D1 (en) FAB I INHIBITORS
AR028253A1 (en) INHIBITORS OF THE GLUCOGENO FOSFORILASA
CY2012007I1 (en) PEPTIDEMIMETIC PROTEASE INHIBITORS
ATE318603T1 (en) PYRROLOTRIAZINE KINASE INHIBITORS
AU2002213048A1 (en) Phosphate transport inhibitors
PT1194404E (en) ASPARTIL-PROTEASE INHIBITORS
DK1272488T3 (en) Tri-aryl-substituted ethane-PDE4 inhibitors
IL147697A0 (en) Phosphate transport inhibitors
NO20014243D0 (en) Dihetero-substituted metalloprotease inhibitors
AU2001259354A1 (en) Phosphate transport inhibitors
NO20025399D0 (en) Phosphate transport inhibitors
NO20032807L (en) Substituted 8-arylquinoline phosphodiesterase-4 inhibitors
NO20014875L (en) Promedients for thrombin inhibitors
DE50108962D1 (en) TRANSPORT SYSTEM
ATE252547T1 (en) MATRIXMETALLOPROTEINASE INHIBITORS
NO20025786L (en) protease inhibitors
PT1339695E (en) FARNESILTRANSFERASE INHIBITORS
NO20024481D0 (en) Difluorobutyric acid metalloprotease inhibitors
NO20025005L (en) protease inhibitors
IS6701A (en) Cdc25 phosphatase inhibitors
DK1130214T3 (en) Corrosion inhibitors
AR028075A1 (en) PEPTIDE-DISFORMILASE INHIBITORS
DE60132468D1 (en) ALEN-LANOSTEROL CYCLES INHIBITORS

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application